.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Progressive keratoconus is driven by progressive corneal biomechanical weakening and can lead to increasing irregular astigmatism and visual loss. A prospective randomized controlled trial evaluated corneal collagen cross-linking in 100 eyes with progressive disease. The treated eyes were compared with control eyes over three years using maximum keratometry, visual acuity, refraction and corneal measurements. Cross-linking stabilised corneal curvature relative to the untreated control group and was associated with visual improvement in several measures. The study provides important evidence that CXL is not simply a refractive procedure—it aims to alter the trajectory of the disease by strengthening the corneal stroma. For HCPs, the critical issue is identifying progression early enough for treatment to preserve corneal shape and visual potential. CXL should be integrated with topography/tomography-based monitoring and appropriate management of allergic eye rubbing and ocular surface disease. The trial directly supports AIOC's emphasis on CXL protocols and management of progressive keratoconus.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Progressive keratoconus is driven by progressive corneal biomechanical weakening and can lead to increasing irregular astigmatism and visual loss. A prospective randomized controlled trial evaluated corneal collagen cross-linking in 100 eyes with progressive disease. The treated eyes were compared with control eyes over three years using maximum keratometry, visual acuity, refraction and corneal measurements. Cross-linking stabilised corneal curvature relative to the untreated control group and was associated with visual improvement in several measures. The study provides important evidence that CXL is not simply a refractive procedure—it aims to alter the trajectory of the disease by strengthening the corneal stroma. For HCPs, the critical issue is identifying progression early enough for treatment to preserve corneal shape and visual potential. CXL should be integrated with topography/tomography-based monitoring and appropriate management of allergic eye rubbing and ocular surface disease. The trial directly supports AIOC's emphasis on CXL protocols and management of progressive keratoconus.
last month
Preclinical findings demonstrate that ginsenoside Ra1 preserves vascular integrity and attenuates multi-organ injury during sepsis by targeting non-muscle myosin heavy chain IIA (NMMHC IIA) and dampening TLR4/NF-κB/NLRP3 inflammatory signaling.
2 days back
An all-printed immunosensing microchip detects urinary sFlt-1 in just 10 minutes with 3.61 pg/mL sensitivity. By leveraging photonic bandgap engineering, this low-cost, cleanroom-free platform provides non-invasive preeclampsia screening, offering substantial benefits for point-of-care obstetric triage.
3 days back
Wearable ultrasound patches are transforming healthcare by shifting medicine from episodic evaluations to continuous monitoring. Discover how flexible acoustic transducers advance cardiovascular tracking, musculoskeletal imaging, neuromodulation, and on-demand closed-loop theranostics.
3 days back
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
Last week
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
Last week
